Adaptive Biotechnologies Corp
ADPTHealthcare·Diagnostics & Research·USA·Mid·NASD·Nov 13 • 6:51 AM ET
29.50+0.02 (0.07%)
2026-11-13 13:06 CET
Market cap
$4.78B
Revenue, TTM
298.01 USD m
Net income, TTM
-70.52 USD m
Free cash flow, TTM
-8.82 USD m
EPS diluted, TTM
-0.45
Price
ADPT against its 20, 50 and 200-day averagesPatternshover a marker to name it
8.4% under the 52-week high of 32.21 on 11 Nov 2026. 52-week low 12.00 on 12 Mar 2026. Last 15 sessions, 29.9% high to low
Volume 0.02× normal · the line is the 50-bar volume average
Setup. RS line 98
CANSLIM 4 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%)
VCP 6 of 6
Minervini 4 of 4
Zanger 2 of 5 — fails: Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 5 of 5
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 1 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 0 of 4 — fails: P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 3 of 4 — fails: Float: Under 100M
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 3 of 3
Profile
ADPT52-week range, 87% of the way up
12.0032.21
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
| Index | RUT |
|---|---|
| Employees | 624 |
| IPO | Jun 27, 2019 |
| Beta | 2.15 |
| ATR, 14d | 1.66 |
| Rel volume | 0.02 |
| Short float | 7.31% |
| Insider own | 2.96% |
| Inst own | 99.40% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | $4.78B |
| Enterprise Value | 4.89B |
| Income | -70.52M |
| Sales | 298.01M |
| Book / share | 1.09 |
| Cash / share | 1.85 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 624 |
| IPO | Jun 27, 2019 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 16.02 |
| Price / book | 27.05 |
| Price / cash | 15.97 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 16.42 |
| Quick Ratio | 3.87 |
| Current Ratio | 3.97 |
| Debt / equity | 2.32 |
| Long-term debt / equity | 2.27 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -0.45 |
|---|---|
| Earnings next year | -0.07 |
| Earnings next quarter | -0.04 |
| Earnings this year | -1.47% |
| Earnings next year | 82.31% |
| Earnings growth, 5 years | - |
| Past earnings growth | 34.64% 18.85% |
| Past sales growth | 14.34% 23.00% |
| Earnings vs last year | 16.01% |
| Sales vs last year | 17.91% |
| Earnings vs last quarter | -73.68% |
| Sales vs last quarter | -10.72% |
| Earnings | Nov 04 AMC |
| Surprise | 121.95% 17.23% |
Ownership
| Insiders own | 2.96% |
|---|---|
| Insider trades | -35.87% |
| Institutions own | 99.40% |
| Institution trades | 6.81% |
| Return on assets | -12.02% |
| Return on equity | -37.05% |
| Return on capital | -12.24% |
| Gross Margin | 71.62% |
| Operating margin | -15.58% |
| Profit Margin | -23.66% |
| 20-day average | 8.93% |
| 50-day average | 9.60% |
| 200-day average | 46.84% |
Technical
| Shares out | 161.57M |
|---|---|
| Shares floating | 157.09M |
| Short / float | 7.31% |
| Short ratio | 5.28 |
| Short interest | 11.48M |
| 52-week high | 32.21 -8.4% |
| 52-week low | 12.00 +145.8% |
| Volatility | 6.85% 6.49% |
| Average range | 1.66 |
| Strength index | 59.82 |
| Market sensitivity | 2.15 |
| Relative volume | 0.02 |
| Avg Volume | 2.18M |
| Volume | 1,958 |
Performance
| Perf Week | 5.43% |
|---|---|
| Perf Month | 15.32% |
| Perf Quarter | 19.09% |
| Perf Half Y | 129.93% |
| Perf YTD | 81.65% |
| Perf Year | 108.63% |
| Perf 3Y | 753.83% |
| Perf 5Y | -11.17% |
| Perf 10Y | - |
| Recommendation | 1.00 |
| Target Price | 32.57 |
| Prev Close | 29.48 |
| Price | 29.50 |
| Change % | 0.07% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Dec 02, 2025 | Resumed | Morgan Stanley | Equal-Weight | $21 | -28.8% |
| Sep 30, 2025 | Initiated | Guggenheim | Buy | $20 | -32.2% |
| Jun 18, 2025 | Initiated | Craig Hallum | Buy | $15 | -49.2% |
| Mar 21, 2025 | Upgrade | Goldman | Neutral → Buy | $9 | -69.5% |
| Jul 05, 2023 | Resumed | JP Morgan | Overweight | $15 | -49.2% |
| Jan 05, 2023 | Initiated | Scotiabank | Sector Outperform | $15 | -49.2% |
| Dec 21, 2022 | Upgrade | Piper Sandler | Neutral → Overweight | $7.50 → $14 | -52.5% |
| Aug 25, 2022 | Initiated | Credit Suisse | Underperform | $8 | -72.9% |
| Jun 03, 2022 | Initiated | Piper Sandler | Neutral | $7.50 | -74.6% |
| Feb 16, 2022 | Reiterated | JP Morgan | Overweight | $75 → $50 | +69.5% |
Peers
Mkt capInsider trading
latest 14 of 100| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Chad Robins | Officer | Nov 11 '26 | Proposed Sale | 29.94 | 73,221 | 2,192,237 | Nov 12 08:56 AM | |
| SUSAN BOBULSKY | Officer | Nov 11 '26 | Proposed Sale | 29.36 | 1,875 | 55,050 | Nov 12 07:55 AM | |
| RUBINSTEIN JULIE | President and COO | Nov 09 '26 | Option Exercise | 12.14 | 11,881 | 144,235 | 389,683 | Nov 10 07:26 PM |
| RUBINSTEIN JULIE | President and COO | Nov 10 '26 | Option Exercise | 12.14 | 11,881 | 144,235 | 389,683 | Nov 10 07:26 PM |
| RUBINSTEIN JULIE | President and COO | Nov 09 '26 | Sale | 30.12 | 11,881 | 357,836 | 377,802 | Nov 10 07:26 PM |
| RUBINSTEIN JULIE | President and COO | Nov 10 '26 | Sale | 29.52 | 11,881 | 350,721 | 377,802 | Nov 10 07:26 PM |
| RUBINSTEIN JULIE | President and COO | Nov 04 '26 | Option Exercise | 12.14 | 11,881 | 144,235 | 389,683 | Nov 06 07:24 PM |
| RUBINSTEIN JULIE | President and COO | Nov 05 '26 | Option Exercise | 12.14 | 11,881 | 144,235 | 389,683 | Nov 06 07:24 PM |
| RUBINSTEIN JULIE | President and COO | Nov 06 '26 | Option Exercise | 12.14 | 11,881 | 144,235 | 389,683 | Nov 06 07:24 PM |
| RUBINSTEIN JULIE | President and COO | Nov 06 '26 | Sale | 27.48 | 11,881 | 326,538 | 377,802 | Nov 06 07:24 PM |
| RUBINSTEIN JULIE | President and COO | Nov 05 '26 | Sale | 26.53 | 11,881 | 315,149 | 377,802 | Nov 06 07:24 PM |
| RUBINSTEIN JULIE | President and COO | Nov 04 '26 | Sale | 26.32 | 11,881 | 312,755 | 377,802 | Nov 06 07:24 PM |
| RUBINSTEIN JULIE | President and COO | Oct 30 '26 | Option Exercise | 12.14 | 11,881 | 144,235 | 389,683 | Nov 03 07:51 PM |
| RUBINSTEIN JULIE | President and COO | Nov 02 '26 | Option Exercise | 12.14 | 11,881 | 144,235 | 389,683 | Nov 03 07:51 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.86B |
| ARKG | ARK Genomic Revolution ETF | AUM: 2.02B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 80.23B |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.25B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| IBB | iShares Biotechnology ETF | AUM: 11.39B |
| FESM | Fidelity Enhanced Small Cap Core ETF | AUM: 6.90B |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | AUM: 22.68B |
| VTWO | Vanguard Russell 2000 Index ETF | AUM: 16.90B |
News
latest 14 of 200- Adaptive Biotechnologies to Participate in Upcoming Investor Conferences (GlobeNewswire)
- Adaptive Biotechnologies Reaches Profitability Early As MRD Momentum Overshadows A Genentech-Distorted Revenue Decline (Earnings Whispers)
- Adaptive Biotechnologies: Q3 Earnings Snapshot (Associated Press)
- Adaptive Biotechnologies Reports Third Quarter 2026 Financial Results (GlobeNewswire)
- Adaptive Biotechnologies Must Show MRD Momentum Can Outrun Its Own Cautious Second-Half Guide (Earnings Whispers) +5.29%
- Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026 (GlobeNewswire)
- Could You Have Seen The Run In Tempus AI Stock Coming? (Trefis)
- Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure (GlobeNewswire)
- Adaptive Biotechnologies Announces Update to NCCN Guidelines for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ (GlobeNewswire)
- Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference (GlobeNewswire)
- What Is Really Moving Tempus AI Stock Right Now? (Trefis)
- Adaptive Biotechnologies Corp (ADPT) (Q2 2026) Earnings Call Highlights: MRD Revenue Surges ... (GuruFocus.com) +7.18%
- Adaptive Biotechnologies: Q2 Earnings Snapshot (Associated Press)
- Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results (GlobeNewswire)
Quarterly earnings
2026Q3 EPS 0.020 beat -0.091, from 0.060 a year earlier. Sales 83.90 beat 71.57, from 93.97 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-04 16:30 | 0.020 | -0.091 | 0.020 | 83.90 | 71.57 | EPS -122.0% · sales +17.2% | vs 2025Q3, year-ago quarter · EPS -66.7% · sales -10.7% | 8 | Open +5.24% vs SPY -0.17%. Close +0.45% vs SPY -4.41% |
| 2026Q2ended 2026-06-30 | 2026-07-29 16:30 | -0.250 | -0.134 | -0.249 | 71.55 | 65.44 | EPS +87.1% · sales +9.3% | vs 2025Q2, year-ago quarter · EPS +47.1% · sales +21.5% | 8 EPS · 7 sales | Open -1.60% vs SPY +0.90%. Close +7.18% vs SPY +1.68% |
| 2026Q1ended 2026-03-31 | 2026-05-05 16:30 | -0.130 | -0.161 | -0.129 | 70.90 | 61.03 | EPS -19.0% · sales +16.2% | vs 2025Q1, year-ago quarter · EPS -35.0% · sales +35.2% | 8 EPS · 7 sales | Open +6.21% vs SPY +0.61%. Close +4.72% vs SPY +1.39% |
| 2025Q4ended 2025-12-31 | 2026-02-05 16:30 | -0.090 | -0.186 | -0.089 | 71.68 | 60.89 | EPS -51.5% · sales +17.7% | vs 2024Q4, year-ago quarter · EPS -60.9% · sales +51.0% | 8 EPS · 7 sales | Open +8.20% vs SPY +0.57%. Close -4.25% vs SPY +1.92% |
| 2025Q3ended 2025-09-30 | 2025-11-05 16:30 | 0.060 | -0.147 | 0.059 | 93.97 | 64.63 | EPS -140.9% · sales +45.4% | vs 2024Q3, year-ago quarter · EPS -127.3% · sales +102.4% | 8 EPS · 7 sales | Open -3.64% vs SPY -0.16%. Close -11.54% vs SPY -1.07% |
| 2025Q2ended 2025-06-30 | 2025-08-05 16:30 | -0.170 | -0.239 | -0.168 | 58.88 | 49.40 | EPS -28.8% · sales +19.2% | vs 2024Q2, year-ago quarter · EPS -45.2% · sales +36.3% | 8 EPS · 7 sales | Open +11.76% vs SPY +0.17%. Close +5.79% vs SPY +0.77% |
| 2025Q1ended 2025-03-31 | 2025-05-01 16:30 | -0.200 | -0.292 | -0.200 | 52.44 | 42.68 | EPS -31.5% · sales +22.9% | vs 2024Q1, year-ago quarter · EPS -39.4% · sales +25.2% | 8 EPS · 7 sales | Open +19.70% vs SPY +1.12%. Close +33.70% vs SPY +1.48% |
| 2024Q4ended 2024-12-31 | 2025-02-11 16:30 | -0.230 | -0.256 | -0.228 | 47.46 | 46.05 | EPS -10.3% · sales +3.1% | vs 2023Q4, year-ago quarter · EPS -52.1% · sales +3.7% | 8 EPS · 7 sales | Open -3.21% vs SPY -1.01%. Close -3.21% vs SPY -0.32% |
| 2024Q3ended 2024-09-30 | 2024-11-07 16:30 | -0.220 | -0.288 | -0.217 | 46.44 | 40.24 | EPS -23.5% · sales +15.4% | vs 2023Q3, year-ago quarter · EPS -37.1% · sales +22.5% | 8 EPS · 7 sales | Open +6.57% vs SPY +0.09%. Close +3.37% vs SPY +0.43% |
| 2024Q2ended 2024-06-30 | 2024-08-01 16:30 | -0.310 | -0.334 | -0.314 | 43.19 | 38.63 | EPS -7.2% · sales +11.8% | vs 2023Q2, year-ago quarter · EPS -6.1% · sales -11.7% | 8 EPS · 7 sales | Open -8.99% vs SPY -1.34%. Close -3.37% vs SPY -1.86% |
| 2024Q1ended 2024-03-31 | 2024-05-07 16:30 | -0.330 | -0.346 | -0.326 | 41.87 | 38.78 | EPS -4.5% · sales +8.0% | vs 2023Q1, year-ago quarter · EPS -17.5% · sales +11.2% | 8 EPS · 7 sales | Open +8.04% vs SPY -0.36%. Close +2.25% vs SPY +0.01% |
| 2023Q4ended 2023-12-31 | 2024-02-14 16:30 | -0.480 | -0.331 | -0.479 | 45.78 | 48.45 | EPS +44.9% · sales -5.5% | vs 2022Q4, year-ago quarter · EPS +71.4% · sales -17.1% | 8 EPS · 7 sales | Open -8.63% vs SPY +0.14%. Close +0.51% vs SPY +0.69% |
| 2023Q3ended 2023-09-30 | 2023-11-09 16:30 | -0.350 | -0.339 | -0.348 | 37.92 | 42.96 | EPS +3.3% · sales -11.7% | vs 2022Q3, year-ago quarter · EPS +9.4% · sales -20.7% | 9 EPS · 8 sales | - |
| 2023Q2ended 2023-06-30 | 2023-08-02 16:30 | -0.330 | -0.347 | -0.331 | 48.93 | 44.87 | EPS -4.8% · sales +9.0% | vs 2022Q2, year-ago quarter · EPS -10.8% · sales +12.1% | 10 EPS · 9 sales | - |
| 2023Q1ended 2023-03-31 | 2023-05-03 16:30 | -0.400 | -0.377 | -0.402 | 37.65 | 36.81 | EPS +6.1% · sales +2.3% | vs 2022Q1, year-ago quarter · EPS -9.1% · sales -2.5% | 10 EPS · 9 sales | - |
| 2022Q4ended 2022-12-31 | 2023-02-14 16:30 | -0.280 | -0.347 | -0.281 | 55.20 | 54.72 | EPS -19.3% · sales +0.9% | vs 2021Q4, year-ago quarter · EPS -34.9% · sales +45.5% | 10 EPS · 9 sales | - |
Annual earnings
2025FY EPS -0.390 beat -0.492, from -1.080 a year earlier. Sales 276.98 beat 265.99, from 178.96 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | 0.040 | - | - | 646.7 | 737.49 |
| 2029FYestimate | - | 0.330 | - | - | 535.65 | 89.39 |
| 2028FYestimate | - | 0.103 | - | - | 462.56 | 285.57 |
| 2027FYestimate | - | -0.070 | - | - | 373.35 | - |
| 2026FYestimate | - | -0.396 | - | - | 307.07 | - |
| 2025FY | -0.390 | -0.492 | -0.390 | 276.98 | 265.99 | - |
| 2024FY | -1.080 | -1.115 | -1.084 | 178.96 | 177.62 | - |
| 2023FY | -1.560 | -1.413 | -1.560 | 170.28 | 172.93 | - |
| 2022FY | -1.400 | -1.471 | -1.405 | 185.31 | 185.1 | - |
| 2021FY | -1.480 | -1.492 | -1.477 | 154.34 | 152.83 | - |
| 2020FY | -1.110 | -1.079 | -1.114 | 98.38 | 95.07 | - |
| 2019FY | -1.010 | -1.007 | -1.006 | 85.07 | 82.57 | - |
Quarterly results
2026Q3 revenue 83.90, from 93.97 a year earlier. Operating margin 0.3%, from 11.0% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E -0.40 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-11-09 | -0.40 | -5.4% |
| 2026Q4 | E | per share | 2026-11-09 | -0.04 | -11.1% |
| 2026Q4 | S | per share | 2026-11-09 | 80.62 | +0.4% |
| 2026FY | S | - | 2026-11-09 | 307.07 | +0.7% |
| 2026FY | R | per share | 2026-11-06 | -0.39 | -16.8% |
| 2026Q4 | R | per share | 2026-11-06 | -0.04 | -9.7% |
| 2026Q3 | E | per share | 2026-10-26 | -0.09 | -0.2% |
| 2026Q3 | S | per share | 2026-10-26 | 71.57 | 0.0% |
| 2026Q3 | R | per share | 2026-10-13 | -0.10 | -0.7% |
| 2026Q2 | E | per share | 2026-07-28 | -0.13 | 0.0% |
| 2026Q2 | S | per share | 2026-07-28 | 65.44 | 0.0% |
| 2026Q2 | R | per share | 2026-07-15 | -0.14 | -1.1% |
| 2026Q1 | E | per share | 2026-04-27 | -0.16 | +0.4% |
| 2026Q1 | R | per share | 2026-04-22 | -0.18 | 0.0% |
| 2026Q1 | S | per share | 2026-04-22 | 61.03 | 0.0% |
| 2025Q4 | S | per share | 2026-01-30 | 60.89 | 0.0% |
| 2025FY | S | - | 2026-01-30 | 265.99 | +0.0% |
| 2025FY | E | per share | 2026-01-24 | -0.49 | 0.0% |
| 2025Q4 | E | per share | 2026-01-24 | -0.19 | 0.0% |
| 2025FY | R | per share | 2026-01-20 | -0.48 | 0.0% |
| 2025Q4 | R | per share | 2026-01-20 | -0.18 | 0.0% |
| 2025Q3 | S | per share | 2025-10-29 | 64.63 | 0.0% |
| 2025Q3 | E | per share | 2025-10-22 | -0.15 | 0.0% |
| 2025Q3 | R | per share | 2025-10-20 | -0.15 | 0.0% |
| 2025Q2 | E | per share | 2025-07-25 | -0.24 | +0.0% |
| 2025Q2 | S | per share | 2025-07-25 | 49.40 | 0.0% |
| 2025Q2 | R | per share | 2025-07-16 | -0.25 | 0.0% |
| 2025Q1 | E | per share | 2025-04-29 | -0.29 | -0.2% |
| 2025Q1 | S | per share | 2025-04-29 | 42.68 | 0.0% |
| 2025Q1 | R | per share | 2025-04-28 | -0.33 | 0.0% |
| 2024FY | E | per share | 2025-02-01 | -1.12 | 0.0% |
| 2024Q4 | E | per share | 2025-02-01 | -0.26 | 0.0% |
| 2024FY | S | - | 2025-02-01 | 177.62 | 0.0% |
| 2024Q4 | S | per share | 2025-01-27 | 46.05 | -0.2% |
| 2024FY | R | per share | 2025-01-22 | -1.12 | 0.0% |
| 2024Q4 | R | per share | 2025-01-22 | -0.26 | +12.0% |
| 2024Q3 | S | per share | 2024-10-28 | 40.24 | +0.1% |
| 2024Q3 | E | per share | 2024-10-20 | -0.29 | 0.0% |
| 2024Q3 | R | per share | 2024-10-16 | -0.28 | 0.0% |
| 2024Q2 | E | per share | 2024-07-31 | -0.33 | 0.0% |
| 2024Q2 | S | per share | 2024-07-31 | 38.63 | 0.0% |
| 2024Q2 | R | per share | 2024-07-22 | -0.32 | 0.0% |
| 2024Q1 | E | per share | 2024-05-01 | -0.35 | 0.0% |
| 2024Q1 | R | per share | 2024-05-01 | -0.36 | 0.0% |
| 2024Q1 | S | per share | 2024-05-01 | 38.78 | 0.0% |
| 2023FY | E | per share | 2024-02-09 | -1.41 | +2.3% |
| 2023FY | S | - | 2024-01-30 | 172.93 | 0.0% |
| 2023FY | R | per share | 2024-01-28 | -1.42 | 0.0% |
Estimate history
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.347 | -0.376 | -1.006 | -1.114 | -1.477 | -1.405 | -1.56 | -1.084 | -0.392 | -0.451 | - |
| Sales USD millions | 38 | 56 | 85 | 98 | 154 | 185 | 170 | 179 | 277 | 298 | - |
| Shares million shares | 123 | 123 | 125 | 138 | 141 | 143 | 145 | 148 | 154 | - | 162 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.217 | -0.228 | -0.2 | -0.168 | 0.059 | -0.089 | -0.129 | -0.249 | 0.015 |
| Sales USD millions | 46 | 47 | 52 | 59 | 94 | 72 | 71 | 72 | 84 |
| Shares million shares | 148 | 148 | 152 | 152 | 153 | 154 | 160 | 159 | 162 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 298.01 | 276.98+54.8% | 178.96+5.1% | 170.28-8.1% | 185.31+20.1% | 154.34+56.9% | 98.38+15.6% | 85.07+52.8% | 55.66 |
| Cost of Goods Sold Incl. D&A | 84.57 | 83.01+0.7% | 82.40-15.7% | 97.78+24.0% | 78.83+24.6% | 63.25+104.0% | 31.00+6.7% | 29.04+23.6% | 23.49 |
| Gross Profit | 213.44 | 193.96+100.9% | 96.55+33.2% | 72.49-31.9% | 106.48+16.9% | 91.09+35.2% | 67.38+20.3% | 56.03+74.2% | 32.17 |
| Selling, General and Administrative Excl. Other | 259.87 | 251.09+0.5% | 249.89-8.8% | 274.10-10.0% | 304.64+1.5% | 300.06+36.3% | 220.20+63.8% | 134.42+64.1% | 81.93 |
| Research and Development | 75.56 | 83.81-11.2% | 94.33-7.1% | 101.58-16.6% | 121.83-6.3% | 130.09+19.0% | 109.30+66.5% | 65.64+77.2% | 37.04 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -46.43 | -57.12 | -153.34 | -201.61 | -198.16 | -208.97 | -152.82 | -78.39 | -49.76 |
| Interest Expense | 9.04 | 11.78+1.7% | 11.58-16.1% | 13.80+225.5% | 4.24 | 0.00 | 0.00 | - | - |
| Unusual Expense | 25.51 | 0.00-100.0% | 9.21-63.8% | 25.43+1158.9% | 2.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | -70.73 | -59.46 | -159.59 | -225.30 | -200.37 | -207.30 | -146.23 | -68.61 | -46.45 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -70.73 | -59.46 | -159.59 | -225.30 | -200.37 | -207.30 | -146.23 | -69.57 | -46.34 |
| Net Income From Continuing Operations | -70.52 | -59.50 | -159.49 | -225.25 | -200.19 | -207.28 | -146.23 | -69.57 | -46.34 |
| Net Income | -70.52 | -59.50 | -159.49 | -225.25 | -200.19 | -207.28 | -146.23 | -69.57 | -46.34 |
| EPS (Recurring) per share | -0.28 | -0.39 | -1.04 | -1.44 | -1.39 | -1.48 | -1.11 | -1.01 | -0.38 |
| EPS (Basic, Before Extraordinaries) per share | -0.45 | -0.39 | -1.08 | -1.56 | -1.40 | -1.48 | -1.11 | -1.01 | -0.38 |
| EPS (Diluted) per share | -0.45 | -0.39 | -1.08 | -1.56 | -1.40 | -1.48 | -1.11 | -1.01 | -0.38 |
| EBITDA | -31.09 | -39.29 | -134.08 | -179.38 | -170.02 | -187.99 | -141.08 | -70.60 | -43.76 |
| Non-Operating Income (Expense) | 10.25 | 9.44-35.0% | 14.53-6.4% | 15.53+282.5% | 4.06+143.1% | 1.67-74.7% | 6.59-32.7% | 9.79+195.8% | 3.31 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.96-1060.0% | 0.10 |
| Stock Option Compensation Expense | 46.15 | 51.48-4.0% | 53.61-14.8% | 62.91+13.4% | 55.48+62.4% | 34.17+89.0% | 18.08+37.8% | 13.12+48.9% | 8.81 |
| Price To Sales Ratio ratio | 18.12 | 8.90 | 4.93 | 4.15 | 5.88 | 25.52 | 78.86 | 24.33 | - |
| Gross Margin % | 71.62 | 70.03 | 53.95 | 42.57 | 57.46 | 59.02 | 68.49 | 65.86 | 57.80 |
| Operating Margin % | -15.58 | -20.62 | -85.69 | -118.40 | -106.94 | -135.39 | -155.33 | -92.15 | -89.39 |
| Net Margin % | -23.66 | -21.48 | -89.12 | -132.29 | -108.03 | -134.30 | -148.63 | -81.78 | -83.26 |
| Shares Outstanding million shares | 161.57 | 153.78+4.1% | 147.77+1.9% | 145.08+1.4% | 143.11+1.2% | 141.39+2.7% | 137.65+9.9% | 125.24+1.6% | 123.22 |
| Market Capitalization | 4,772.13 | 4,772.13+439.4% | 884.74+24.7% | 709.39-35.1% | 1,092.61-72.4% | 3,960.16-51.0% | 8,087.33+117.4% | 3,720.22+3.4% | 3,599.61 |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 83.90-10.7% | 71.55+21.5% | 70.87+35.1% | 71.68+51.0% | 93.97+102.3% | 58.88+36.3% | 52.44+25.2% | 47.46+3.7% |
| Cost of Goods Sold Incl. D&A | 21.82+2.3% | 21.36+1.5% | 20.87+3.8% | 20.52+0.6% | 21.33+11.5% | 21.05-4.8% | 20.11-3.3% | 20.39-18.5% |
| Gross Profit | 62.09-14.5% | 50.19+32.7% | 50.01+54.6% | 51.16+89.0% | 72.64+166.0% | 37.83+79.4% | 32.34+53.3% | 27.07+30.3% |
| Selling, General and Administrative Excl. Other | 61.83-0.8% | 65.89+4.8% | 68.22+10.1% | 63.93+5.1% | 62.35+4.4% | 62.86+3.9% | 61.94-11.3% | 60.82-8.4% |
| Research and Development | 16.47-21.3% | 18.30-14.9% | 20.89-2.8% | 19.89-6.5% | 20.93-5.4% | 21.50-6.5% | 21.50-23.0% | 21.28-10.5% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 0.26-97.5% | -15.69 | -18.22 | -12.77 | 10.29 | -25.04 | -29.60 | -33.75 |
| Interest Expense | 0.50-83.2% | 2.69-8.8% | 2.89-0.3% | 2.950.0% | 2.97+1.0% | 2.95+9.3% | 2.90-3.0% | 2.95-2.0% |
| Unusual Expense | 0.71 | 23.81 | 0.99 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.00 | 0.09-99.6% |
| Net Income Before Taxes | 2.81-70.5% | -39.94 | -20.02 | -13.58 | 9.54 | -25.59 | -29.83 | -33.72 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | 2.81-70.5% | -39.94 | -20.02 | -13.58 | 9.54 | -25.59 | -29.83 | -33.72 |
| Net Income From Continuing Operations | 2.88-69.8% | -39.79 | -20.03 | -13.58 | 9.55 | -25.61 | -29.85 | -33.69 |
| Net Income | 2.88-69.8% | -39.79 | -20.03 | -13.58 | 9.55 | -25.61 | -29.85 | -33.69 |
| EPS (Recurring) per share | 0.02-66.7% | -0.14 | -0.12 | -0.09 | 0.06 | -0.17 | -0.20 | -0.23 |
| EPS (Basic, Before Extraordinaries) per share | 0.02-66.7% | -0.25 | -0.13 | -0.09 | 0.06 | -0.17 | -0.20 | -0.23 |
| EPS (Diluted) per share | 0.02-66.7% | -0.25 | -0.13 | -0.09 | 0.06 | -0.17 | -0.20 | -0.23 |
| EBITDA | 3.86-73.7% | -12.00 | -14.38 | -8.58 | 14.70 | -20.53 | -24.87 | -29.30 |
| Non-Operating Income (Expense) | 3.77+69.1% | 2.26-5.4% | 2.08-22.4% | 2.15-30.0% | 2.23-35.7% | 2.39-36.6% | 2.68-36.5% | 3.07-33.4% |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 10.39-21.6% | 11.12-16.8% | 11.93-1.8% | 12.72-0.9% | 13.26-1.9% | 13.36+3.1% | 12.15+7.5% | 12.83-17.5% |
| Price To Sales Ratio ratio | 18.12 | 11.13 | 7.31 | 8.98 | 9.66 | 8.63 | 5.85 | 4.95 |
| Gross Margin % | 74.00 | 70.15 | 70.56 | 71.37 | 77.30 | 64.24 | 61.66 | 57.04 |
| Operating Margin % | 0.30 | -21.93 | -25.70 | -17.82 | 10.95 | -42.52 | -56.45 | -71.11 |
| Net Margin % | 3.43 | -55.61 | -28.27 | -18.94 | 10.16 | -43.50 | -56.92 | -70.99 |
| Shares Outstanding million shares | 161.57+5.9% | 159.06+4.5% | 159.70+5.1% | 153.78+4.1% | 152.58+3.4% | 152.23+3.2% | 151.92+3.1% | 147.77+1.9% |
| Market Capitalization | 4,772.13+109.5% | 3,432.94+94.0% | 2,137.27+93.6% | 2,479.28+180.2% | 2,278.02+201.7% | 1,769.83+231.8% | 1,103.96+137.0% | 884.74+24.7% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 | 2017FY12/31/2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 226.98+2.1% | 222.29-35.8% | 346.40-30.5% | 498.20+41.1% | 353.06-48.7% | 688.27+19.3% | 576.87+249.6% | 165.02-14.1% | 192.15 |
| Short Term Receivables | 51.87+20.5% | 43.03+10.4% | 38.97-4.6% | 40.86+117.2% | 18.81+49.9% | 12.55-1.0% | 12.68+163.6% | 4.81-13.8% | 5.58 |
| Inventories | 9.82+16.4% | 8.44-41.6% | 14.450.0% | 14.45-25.0% | 19.26+37.0% | 14.06+55.0% | 9.07+15.7% | 7.84+63.7% | 4.79 |
| Other Current Assets | 11.52+15.3% | 9.99-3.7% | 10.37+20.0% | 8.64-25.6% | 11.62-3.5% | 12.04-14.5% | 14.08+360.1% | 3.06+12.5% | 2.72 |
| Total Current Assets | 300.19+5.8% | 283.75-30.8% | 410.19-27.0% | 562.15+39.6% | 402.75-44.6% | 726.91+18.6% | 612.69+239.0% | 180.72-12.0% | 205.25 |
| Net Property, Plant & Equipment | 74.72-20.8% | 94.38-21.6% | 120.32-26.7% | 164.21-5.0% | 172.94+24.4% | 139.04+130.4% | 60.35+215.6% | 19.12+37.1% | 13.95 |
| Total Investments and Advances | 15.92-56.5% | 36.56+1147.8% | 2.93+22.1% | 2.40-98.9% | 219.28+81.7% | 120.66+12.2% | 107.57+42928.0% | 0.25-97.2% | 8.99 |
| Intangible Assets | 120.70-1.4% | 122.40-1.4% | 124.10-1.4% | 125.80-1.3% | 127.50-1.3% | 129.20-1.3% | 130.90-1.3% | 132.60-1.3% | 134.30 |
| Deferred Tax Assets | 451.30 | - | - | - | - | - | - | - | - |
| Other Assets | 1.21-47.2% | 2.29-36.2% | 3.59+74.3% | 2.06+134.1% | 0.88+46.7% | 0.60-23.1% | 0.78 | 0.00 | 0.00 |
| Total Assets | 964.03+78.7% | 539.38-18.4% | 661.13-22.8% | 856.62-7.2% | 923.34-17.3% | 1,116.41+22.4% | 912.30+174.2% | 332.69-8.2% | 362.49 |
| Short Term Debt Incl. Current Port. of LT Debt | 13.56+22.2% | 11.10+18.3% | 9.38+1.6% | 9.23+82.8% | 5.05+43.1% | 3.53 | 0.00 | 0.00 | 0.00 |
| Accounts Payable | 6.47-10.9% | 7.26-6.0% | 7.72-4.5% | 8.08+144.1% | 3.31+2.2% | 3.24-27.2% | 4.45+148.6% | 1.79-8.7% | 1.96 |
| Other Current Liabilities | 69.89-12.3% | 79.68+12.4% | 70.91-23.3% | 92.47-12.3% | 105.44+7.1% | 98.43+33.3% | 73.86+251.5% | 21.01+10.3% | 19.04 |
| Total Current Liabilities | 89.92-8.3% | 98.05+11.4% | 88.02-19.8% | 109.79-3.5% | 113.81+8.2% | 105.20+34.3% | 78.31+243.5% | 22.80+8.6% | 21.00 |
| Long Term Debt | 196.79-7.0% | 211.56-3.9% | 220.05-1.8% | 224.13+110.1% | 106.69+2.3% | 104.33+185.0% | 36.61-93.5% | 561.19-0.1% | 561.67 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 451.30 | - | - | - | - | - | - | - | - |
| Other Liabilities | 1.03-96.2% | 27.28-39.1% | 44.79-23.6% | 58.60-40.7% | 98.75-39.6% | 163.62-27.7% | 226.34+3223.6% | 6.81+53.7% | 4.43 |
| Total Liabilities | 739.03+119.4% | 336.89-4.5% | 352.86-10.1% | 392.52+23.0% | 319.24-14.4% | 373.15+9.3% | 341.26-42.2% | 590.80+0.6% | 587.11 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 218.79+7.9% | 202.71-34.3% | 308.40-33.6% | 464.17-23.1% | 603.99-18.7% | 743.27+30.2% | 571.04 | -258.11 | -224.62 |
| Total Shareholders Equity | 218.79+7.9% | 202.71-34.3% | 308.40-33.6% | 464.17-23.1% | 603.99-18.7% | 743.27+30.2% | 571.04 | -258.11 | -224.62 |
| Accumulated Minority Interest | 6.21 | -0.22 | -0.12 | -0.07-163.6% | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 225.00+11.1% | 202.49-34.3% | 308.28-33.6% | 464.10-23.2% | 604.10-18.7% | 743.27+30.2% | 571.04 | -258.11 | -224.62 |
| Total Liabilities & Stockholders Equity | 964.03+78.7% | 539.38-18.4% | 661.13-22.8% | 856.62-7.2% | 923.34-17.3% | 1,116.41+22.4% | 912.30+174.2% | 332.69-8.2% | 362.49 |
| Book Value Per Share per share | 1.42+3.6% | 1.37-35.7% | 2.13-34.3% | 3.24-24.1% | 4.27-20.9% | 5.40+18.4% | 4.56 | -2.09 | -1.82 |
| Tangible Book Value Per Share per share | 0.64+18.5% | 0.54-57.5% | 1.27-46.2% | 2.36-30.0% | 3.37-24.4% | 4.46+27.1% | 3.51 | -3.17 | -2.91 |
| Full-Time Employees people | 624+0.8% | 619-12.7% | 709-10.3% | 790-7.9% | 858+37.9% | 622+37.3% | 453+30.9% | 346 | - |
| Price to Book Ratio ratio | 27.03 | 3.95 | 1.96 | 2.24 | 6.57 | 10.95 | 6.56 | 6.14 | - |
| Return on Assets % | -7.92 | -26.57 | -29.68 | -22.49 | -20.32 | -14.42 | -11.18 | -13.33 | - |
| Return on Equity % | -28.23 | -62.41 | -58.31 | -37.48 | -30.77 | -22.25 | -44.46 | - | - |
| Return on Invested Capital % | -14.32 | -38.50 | -42.62 | -29.08 | -29.17 | -17.25 | -11.45 | -15.29 | -12.67 |
| Quick Ratio ratio | 3.23 | 2.81 | 4.50 | 4.99 | 3.37 | 6.78 | 7.71 | 7.58 | 9.54 |
| Current Ratio ratio | 3.34 | 2.89 | 4.66 | 5.12 | 3.54 | 6.91 | 7.82 | 7.93 | 9.77 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -70.73 | -59.46 | -159.59 | -225.30 | -200.37 | -207.30 | -146.23 | -68.61 | -46.45 |
| Depreciation | 15.33 | 17.83-7.4% | 19.26-33.9% | 29.15+3.6% | 28.15+34.2% | 20.98+78.7% | 11.74+50.7% | 7.79+29.8% | 6.00 |
| Other Funds (Non Cash) | 67.67 | 53.41-14.7% | 62.58-27.2% | 86.01+43.8% | 59.82+18.7% | 50.41+96.8% | 25.61+126.8% | 11.29+13.9% | 9.91 |
| Funds from Operations | 12.27 | 11.78 | -77.76 | -110.14 | -112.40 | -135.91 | -108.88 | -49.53 | -30.54 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -16.55 | -57.77 | -17.45 | -46.18 | -71.55 | -56.82 | -40.80-116.0% | 254.93 | -1.72 |
| Cash from Operating Activities | -4.28 | -45.99 | -95.21 | -156.32 | -183.94 | -192.73 | -149.68-172.9% | 205.40 | -32.26 |
| Capital Expenditures | -4.54 | -2.96 | -3.66 | -10.70 | -16.35 | -61.75 | -18.80 | -11.20 | -6.32 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.02 |
| Purchase or Sale of Investments | -163.10 | 40.91-49.8% | 81.46-42.0% | 140.34+629.0% | 19.25-92.1% | 242.96 | -98.24 | -470.50-6783.2% | 7.04 |
| Purchase of Investments | -333.30 | -181.71 | -244.26 | -429.56 | -278.78 | -316.54 | -694.97 | -884.22 | -146.50 |
| Sale Or Maturity of Investments | 170.20 | 222.62-31.7% | 325.71-42.8% | 569.90+91.2% | 298.03-46.7% | 559.50-6.2% | 596.72+44.2% | 413.72+169.5% | 153.54 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -167.65 | 37.95-51.2% | 77.79-40.0% | 129.65+4370.7% | 2.90-98.4% | 181.21 | -117.04 | -481.70-65194.6% | 0.74 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 31.39 | 30.40+12566.7% | 0.24-89.3% | 2.25-71.5% | 7.89-70.5% | 26.72-90.9% | 293.59-8.2% | 319.93+25091.3% | 1.27 |
| Repurchase of Common Pref Stock | -25.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 56.39 | 30.40+12566.7% | 0.24-89.3% | 2.25-71.5% | 7.89-70.5% | 26.72-90.9% | 293.59-8.2% | 319.93+25091.3% | 1.27 |
| Proceedsfrom Stock Options | 15.00 | 12.52 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 271.84-13.9% | 315.86 | 0.00 |
| Issuance or Reduction of Debt, Net | 161.13 | 0.00 | 0.00 | 0.00-100.0% | 124.38 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | 161.13 | 0.00 | 0.00 | 0.00-100.0% | 124.38 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 334.83 | 0.00 | 0.00 | 0.00-100.0% | 124.38 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -173.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.43 | 0.00 | -0.01 | -0.02 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 |
| Cash from Financing Activities | 192.52 | 30.40+12566.7% | 0.24-89.3% | 2.25-98.3% | 132.26+387.1% | 27.15-90.8% | 293.59-8.2% | 319.92+25493.6% | 1.25 |
| Net Change in Cash | 20.60 | 22.37 | -17.18 | -24.43 | -48.77-412.0% | 15.63-41.8% | 26.86-38.4% | 43.62 | -30.27 |
| Free Cash Flow | -8.82 | -48.95 | -98.88 | -167.02 | -200.29 | -254.47 | -168.49-186.8% | 194.20 | -38.58 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow ratio | - | - | - | - | - | - | - | 10.66 | - |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 298.95+40.5% | 344.25+74.0% | 218.33+12.9% | 226.98+2.1% | 212.77-12.6% | 197.87-32.2% | 193.42-37.4% | 222.29-35.8% |
| Short Term Receivables | 69.27+49.5% | 51.31+12.5% | 49.91+10.7% | 51.87+20.5% | 46.32+10.0% | 45.59+23.9% | 45.08+4.5% | 43.03+10.4% |
| Inventories | 10.05+1.2% | 10.50+25.0% | 11.21+29.1% | 9.82+16.4% | 9.93-17.0% | 8.40-36.4% | 8.68-34.7% | 8.44-41.6% |
| Other Current Assets | 14.41+16.1% | 14.50+45.1% | 12.35+32.8% | 11.52+15.3% | 12.41+13.3% | 9.99+3.5% | 9.30+6.3% | 9.99-3.7% |
| Total Current Assets | 392.69+39.5% | 420.56+60.6% | 291.81+13.8% | 300.19+5.8% | 281.44-8.7% | 261.86-25.5% | 256.49-31.4% | 283.75-30.8% |
| Net Property, Plant & Equipment | 65.96-17.0% | 68.57-18.7% | 71.02-19.7% | 74.72-20.8% | 79.49-18.8% | 84.39-18.8% | 88.43-23.9% | 94.38-21.6% |
| Total Investments and Advances | 103.93+1444.3% | 30.21+12.6% | 21.60-48.7% | 15.92-56.5% | 6.73-74.9% | 26.82+800.0% | 42.07+1321.3% | 36.56+1147.8% |
| Intangible Assets | 119.43-1.4% | 119.86-1.4% | 120.28-1.4% | 120.70-1.4% | 121.13-1.4% | 121.56-1.4% | 121.98-1.4% | 122.40-1.4% |
| Deferred Tax Assets | - | - | - | 451.30 | - | - | - | - |
| Other Assets | 1.11-39.7% | 1.48-26.4% | 1.24-34.4% | 1.21-47.2% | 1.84-30.6% | 2.01-36.2% | 1.89-44.2% | 2.29-36.2% |
| Total Assets | 683.12+39.2% | 640.68+29.0% | 505.94-1.0% | 964.03+78.7% | 490.61-12.2% | 496.64-15.1% | 510.85-17.6% | 539.38-18.4% |
| Short Term Debt Incl. Current Port. of LT Debt | 9.14-23.0% | 8.82-32.3% | 14.32+14.8% | 13.56+22.2% | 11.87+18.5% | 13.03+32.8% | 12.47+30.0% | 11.10+18.3% |
| Accounts Payable | 6.53-36.4% | 5.24-24.2% | 9.62+51.3% | 6.47-10.9% | 10.27+39.7% | 6.91-30.0% | 6.36-47.7% | 7.26-6.0% |
| Other Current Liabilities | 83.30+36.1% | 73.65+2.0% | 63.08-8.5% | 69.89-12.3% | 61.22-12.9% | 72.21+5.5% | 68.97+12.7% | 79.68+12.4% |
| Total Current Liabilities | 98.97+18.7% | 87.71-4.8% | 87.01-0.9% | 89.92-8.3% | 83.36-4.9% | 92.14+4.6% | 87.81+5.9% | 98.05+11.4% |
| Long Term Debt | 399.83+98.2% | 401.68+96.0% | 193.86-6.8% | 196.79-7.0% | 201.77-5.9% | 204.91-5.3% | 207.99-4.8% | 211.56-3.9% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | - | - | - | 451.30 | - | - | - | - |
| Other Liabilities | 0.43-65.0% | 0.63-96.9% | 0.83-96.7% | 1.03-96.2% | 1.23-96.3% | 20.05-48.4% | 24.83-43.8% | 27.28-39.1% |
| Total Liabilities | 499.23+74.3% | 490.02+54.5% | 281.70-12.1% | 739.03+119.4% | 286.36-14.5% | 317.10-7.7% | 320.63-7.2% | 336.89-4.5% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 176.21-13.8% | 142.91-20.5% | 216.34+13.6% | 218.79+7.9% | 204.44-8.6% | 179.72-25.6% | 190.42-30.7% | 202.71-34.3% |
| Total Shareholders Equity | 176.21-13.8% | 142.91-20.5% | 216.34+13.6% | 218.79+7.9% | 204.44-8.6% | 179.72-25.6% | 190.42-30.7% | 202.71-34.3% |
| Accumulated Minority Interest | 7.68 | 7.75 | 7.90 | 6.21 | -0.18 | -0.18 | -0.20 | -0.22 |
| Total Equity | 183.89-10.0% | 150.66-16.1% | 224.24+17.9% | 225.00+11.1% | 204.25-8.6% | 179.54-25.6% | 190.22-30.8% | 202.49-34.3% |
| Total Liabilities & Stockholders Equity | 683.12+39.2% | 640.68+29.0% | 505.94-1.0% | 964.03+78.7% | 490.61-12.2% | 496.64-15.1% | 510.85-17.6% | 539.38-18.4% |
| Book Value Per Share per share | 1.09-18.7% | 0.90-23.7% | 1.35+8.0% | 1.42+3.6% | 1.34-11.8% | 1.18-28.0% | 1.25-33.2% | 1.37-35.7% |
| Tangible Book Value Per Share per share | 0.35-36.4% | 0.14-63.2% | 0.60+33.3% | 0.64+18.5% | 0.55-19.1% | 0.38-52.5% | 0.45-56.3% | 0.54-57.5% |
| Full-Time Employees people | - | - | - | 624+0.8% | - | - | - | 619-12.7% |
| Price to Book Ratio ratio | 27.03 | 15.83 | 9.76 | 12.12 | 12.67 | 9.29 | 5.42 | 3.95 |
| Return on Assets % | -12.02 | -11.23 | -9.77 | -7.92 | -15.18 | -22.42 | -25.08 | -26.57 |
| Return on Equity % | -37.05 | -39.58 | -24.43 | -28.23 | -37.18 | -57.55 | -60.96 | -62.41 |
| Return on Invested Capital % | 0.50 | -7.31 | -4.88 | -3.27 | 2.35 | -6.66 | -7.49 | -8.13 |
| Quick Ratio ratio | 3.87 | 4.68 | 3.22 | 3.23 | 3.26 | 2.75 | 2.82 | 2.81 |
| Current Ratio ratio | 3.97 | 4.79 | 3.35 | 3.34 | 3.38 | 2.84 | 2.92 | 2.89 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | 2.81-70.5% | -39.94 | -20.02 | -13.58 | 9.54 | -25.59 | -29.83 | -33.72 |
| Depreciation | 3.61-18.1% | 3.69-18.0% | 3.84-18.8% | 4.20-5.6% | 4.41-3.9% | 4.50-10.0% | 4.73-9.2% | 4.45-34.8% |
| Other Funds (Non Cash) | 11.21-12.4% | 29.62+112.0% | 12.94+1.4% | 13.89+1.2% | 12.79-5.0% | 13.97-33.9% | 12.76-10.6% | 13.72-65.0% |
| Funds from Operations | 17.63-34.1% | -6.62 | -3.24 | 4.51 | 26.74 | -7.12 | -12.34 | -15.54 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -8.02 | 0.22 | -6.29 | -2.45-180.3% | -33.87 | -5.30-287.3% | -16.14 | 3.05 |
| Cash from Operating Activities | 9.61 | -6.40 | -9.54 | 2.06 | -7.13 | -12.43 | -28.48 | -12.49 |
| Capital Expenditures | -1.93 | -1.18 | -0.80 | -0.64 | -0.41 | -0.66 | -1.26 | -0.08 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | -123.13-796.0% | -42.29-1157.3% | 9.94-63.0% | -7.62-134.3% | 17.69+214.2% | 4.00-47.4% | 26.83-41.7% | 22.20+393.3% |
| Purchase of Investments | -164.98 | -82.72 | -38.86 | -46.73 | -33.19 | -51.14 | -50.65 | -44.80 |
| Sale Or Maturity of Investments | 41.85-17.7% | 40.43-26.7% | 48.80-37.0% | 39.12-41.6% | 50.88-26.1% | 55.14-39.0% | 77.49-22.1% | 67.00-47.0% |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -125.06-823.7% | -43.48-1397.9% | 9.14-64.3% | -8.25-137.3% | 17.28+226.7% | 3.35-43.0% | 25.57-42.6% | 22.12+589.1% |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 21.85+1200.6% | -19.62-1318.6% | 7.50+37.6% | 21.66+16561.5% | 1.68+4100.0% | 1.61+5266.7% | 5.45+13525.0% | 0.13+44.4% |
| Repurchase of Common Pref Stock | 0.00 | -25.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 21.85+1200.6% | 5.38+234.2% | 7.50+37.6% | 21.66+16561.5% | 1.68+4100.0% | 1.61+5266.7% | 5.45+13525.0% | 0.13+44.4% |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 2.48 | 12.52 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -0.68 | 161.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | -0.68 | 161.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | -0.68 | 335.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | -173.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 21.17+1160.1% | 142.19+8731.7% | 7.50+37.6% | 21.66+16561.5% | 1.68+4100.0% | 1.61+5266.7% | 5.45+13525.0% | 0.13+44.4% |
| Net Change in Cash | -94.28-896.3% | 92.31 | 7.11+179.9% | 15.46+58.4% | 11.84 | -7.47 | 2.54-59.0% | 9.76 |
| Free Cash Flow | 7.68 | -7.58 | -10.33 | 1.42 | -7.54 | -13.09 | -29.74 | -12.57 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Collaboration | 13.45 | 41.28 | +206.9% | 14.9% |
| Regulatory Milestone | 12.50 | 19.50 | +56.0% | 7.0% |
| Service | 133.03 | 192.83 | +45.0% | 69.6% |
| Service And Licensing | 19.98 | 23.36 | +16.9% | 8.4% |
| Total | 178.96 | 276.98 | +54.8% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| United States | 178.96 | 276.98 | +54.8% | 100.0% |
| Total | 178.96 | 276.98 | +54.8% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Immune Medicine Business | 33.43 | 64.64 | +93.4% | 23.3% |
| MRD Business | 145.53 | 212.33 | +45.9% | 76.7% |
| Total | 178.96 | 276.98 | +54.8% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 7.31% | 11.5M | 157.1M | 2.18M |
| 2026-10-15 | 7.74% | 12.0M | 154.9M | 2.35M |
| 2026-09-30 | 7.65% | 11.8M | 154.9M | 2.39M |
| 2026-09-15 | 8.71% | 13.5M | 154.9M | 2.77M |
| 2026-08-31 | 7.56% | 11.7M | 154.9M | 2.93M |
| 2026-08-14 | 8.60% | 13.3M | 154.9M | 2.91M |
| 2026-07-31 | 8.07% | 12.5M | 154.8M | 2.86M |
| 2026-07-15 | 7.35% | 11.4M | 155.0M | 2.56M |
| 2026-06-30 | 7.34% | 11.4M | 154.6M | 2.44M |
| 2026-06-15 | 4.95% | 7.6M | 154.5M | 1.96M |
| 2026-05-29 | 5.33% | 8.2M | 154.5M | 1.92M |
| 2026-05-15 | 5.78% | 8.9M | 154.0M | 1.90M |
| 2026-04-30 | 5.48% | 8.4M | 154.0M | 1.93M |
| 2026-04-15 | 5.77% | 8.6M | 148.2M | 2.01M |
| 2026-03-31 | 5.77% | 8.6M | 148.4M | 2.06M |
| 2026-03-13 | 6.23% | 9.2M | 148.4M | 2.05M |
| 2026-02-27 | 5.98% | 8.9M | 148.4M | 2.17M |
| 2026-02-13 | 6.25% | 9.2M | 147.1M | 2.38M |
| 2026-01-30 | 6.14% | 9.0M | 147.1M | 2.37M |
| 2026-01-15 | 6.14% | 9.0M | 146.9M | 2.34M |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 12.50 | 15.10 | 19.50 | 0.00 | 7.657 | 0.00 | 0.00 | 0.954 | -0.114 | 0.004 |
| call | 15.00 | 12.60 | 17.00 | 0.00 | 6.346 | 0.00 | 0.00 | 0.943 | -0.111 | 0.005 |
| call | 17.50 | 10.10 | 14.50 | 0.00 | 5.273 | 0.00 | 0.00 | 0.930 | -0.106 | 0.006 |
| call | 20.00 | 7.60 | 12.00 | 0.00 | 4.354 | 0.00 | 0.00 | 0.912 | -0.100 | 0.007 |
| call | 22.50 | 5.20 | 9.50 | 4.00 | 3.537 | 1.00 | 0.00 | 0.887 | -0.092 | 0.008 |
| call | 25.00 | 4.40 | 6.80 | 4.40 | 2.642 | 25.00 | 1.00 | 0.847 | -0.081 | 0.010 |
| call | 30.00 | 0.90 | 1.80 | 1.35 | 1.174 | 1,651 | 3.00 | 0.507 | -0.152 | 0.017 |
| call | 35.00 | 0.00 | 0.40 | 0.40 | 1.115 | 108 | 2.00 | 0.168 | -0.078 | 0.011 |
| call | 40.00 | 0.00 | 1.85 | 0.10 | 1.639 | 4.00 | 0.00 | 0.126 | -0.094 | 0.009 |
| put | 12.50 | 0.00 | 1.85 | 0.00 | 4.266 | 0.00 | 0.00 | -0.046 | -0.113 | 0.004 |
| put | 15.00 | 0.00 | 1.85 | 0.00 | 2.999 | 0.00 | 0.00 | -0.040 | -0.071 | 0.004 |
| put | 17.50 | 0.00 | 1.85 | 0.05 | 2.814 | 1.00 | 0.00 | -0.070 | -0.104 | 0.006 |
| put | 20.00 | 0.00 | 1.85 | 0.00 | 1.885 | 0.00 | 0.00 | -0.063 | -0.064 | 0.005 |
| put | 22.50 | 0.00 | 1.75 | 0.10 | 1.703 | 1,427 | 0.00 | -0.113 | -0.089 | 0.008 |
| put | 25.00 | 0.00 | 0.45 | 0.25 | 1.208 | 16.00 | 4.00 | -0.153 | -0.078 | 0.010 |
| put | 30.00 | 1.25 | 3.10 | 1.35 | 1.642 | 9.00 | 0.00 | -0.493 | -0.149 | 0.017 |
| put | 35.00 | 3.90 | 7.40 | 8.95 | 2.182 | 1.00 | 0.00 | -0.832 | -0.074 | 0.011 |
| put | 40.00 | 8.70 | 12.40 | 0.00 | 2.843 | 0.00 | 0.00 | -0.874 | -0.089 | 0.009 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-12 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-11-12 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-11-12 | 4 | Statement of changes in beneficial ownership of securities | 2026-11-09 | SEC |
| 2026-11-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-11-09 | SEC |
| 2026-11-06 | 4 | Statement of changes in beneficial ownership of securities | 2026-11-04 | SEC |
| 2026-11-04 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-04 | 8-K | Current report | 2026-11-04 | SEC |
| 2026-11-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-30 | SEC |
| 2026-10-29 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-27 | SEC |
| 2026-10-26 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-22 | SEC |
| 2026-10-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-19 | SEC |
| 2026-10-16 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-14 | SEC |
| 2026-10-13 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-09 | SEC |
| 2026-10-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-06 | SEC |
| 2026-10-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-06 | SEC |
| 2026-10-06 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-01 | SEC |
| 2026-10-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-01 | SEC |
| 2026-10-01 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-18 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-16 | SEC |
| 2026-09-17 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-15 | SEC |
| 2026-09-16 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-15 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-31 | SEC |
| 2026-08-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-26 | SEC |
| 2026-08-26 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-20 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-20 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-18 | SEC |
| 2026-08-19 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-19 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-17 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 2.27M | 7 |
| 2026-10 | 0 | 0 | 7.82M | 24 |
| 2026-09 | 0 | 0 | 3.27M | 2 |
| 2026-08 | 0 | 0 | 19.09M | 6 |
| 2026-07 | 0 | 0 | 23.99M | 8 |
| 2026-06 | 0 | 0 | 6.34M | 7 |
| 2026-05 | 0 | 0 | 40.62K | 1 |
| 2026-04 | 0 | 0 | 7.46M | 22 |
| 2026-03 | 0 | 0 | 29.91M | 34 |
| 2026-02 | 0 | 0 | 6.07M | 5 |
| 2026-01 | 0 | 0 | 3.65M | 5 |
| 2025-12 | 0 | 0 | 5.47M | 7 |
| 2025-11 | 0 | 0 | 15.49M | 9 |
Institutional holders
| Manager | % owned |
|---|---|
| VIKING GLOBAL INVESTORS LP | 18.74% |
| BlackRock, Inc. | 9.46% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 3.69% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.42% |
| D. E. Shaw & Co., Inc. | 2.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 2.33% |
| STATE STREET CORP | 2.23% |
| Invesco Ltd. | 2.02% |
| GOLDMAN SACHS GROUP INC | 1.86% |
Funds
| Fund | % owned |
|---|---|
| CALAMOS STRATEGIC TOTAL RETURN FUND | 5.78% |
| iShares Convertible Bond ETF | 5.12% |
| Columbia Convertible Securities Fund | 4.97% |
| Lord Abbett Convertible Fund | 4.39% |
| Calamos Growth & Income Fund | 4.37% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 3.02% |
| Calamos Convertible Fund | 2.97% |
| CALAMOS CONVERTIBLE & HIGH INCOME FUND | 2.97% |
| Miller Market Neutral Income Fund | 2.85% |
| CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND | 2.66% |
OakChart. ADPT. Cached 15 minutes. Terms